Analyzing collaboration dynamics in new drug R&D: A case study of two lipid-lowering drugs
New drug R&D research collaboration patterns evolve spontaneously with productivity updates. In the future, it is necessary to enhance the involvement of pharmaceutical companies in the basic research phase of new drug development, continuously strengthen the relationships across all segments of the academic chain, and thoroughly boost the efficiency of transforming new drug R&D into practical applications.
Authors
- Hanxu Guo (ORCID: https://orcid.org/0000-0001-8004-7965)
- Ruonan Tian (ORCID: https://orcid.org/0009-0003-6018-397X)
- Nan Zhang (ORCID: https://orcid.org/0000-0002-9675-5322)
- Chen Wang
- Mengchao Zhang (ORCID: https://orcid.org/0000-0002-3733-1597)
- Zhiguang Duan
- Yan Shi (ORCID: https://orcid.org/0000-0002-4157-6167)
Institutions
- Shanxi Medical University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-05-30
- DOI
- https://doi.org/10.3389/fphar.2025.1516882
- Citations
- 2
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 3.01